These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8647823)

  • 1. Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor.
    Li S; Resnicoff M; Baserga R
    J Biol Chem; 1996 May; 271(21):12254-60. PubMed ID: 8647823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
    Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
    Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
    Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R
    Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain.
    Li S; Ferber A; Miura M; Baserga R
    J Biol Chem; 1994 Dec; 269(51):32558-64. PubMed ID: 7798258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential effects of pp120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor.
    Soni P; Lakkis M; Poy MN; Fernström MA; Najjar SM
    Mol Cell Biol; 2000 Jun; 20(11):3896-905. PubMed ID: 10805733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis.
    O'Connor R; Kauffmann-Zeh A; Liu Y; Lehar S; Evan GI; Baserga R; Blättler WA
    Mol Cell Biol; 1997 Jan; 17(1):427-35. PubMed ID: 8972223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth.
    Blakesley VA; Koval AP; Stannard BS; Scrimgeour A; LeRoith D
    J Biol Chem; 1998 Jul; 273(29):18411-22. PubMed ID: 9660809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor.
    Miura M; Surmacz E; Burgaud JL; Baserga R
    J Biol Chem; 1995 Sep; 270(38):22639-44. PubMed ID: 7673254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.
    Kato H; Faria TN; Stannard B; Roberts CT; LeRoith D
    Mol Endocrinol; 1994 Jan; 8(1):40-50. PubMed ID: 7512194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
    Valverde AM; Teruel T; Lorenzo M; Benito M
    Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I receptor activated by a transmembrane mutation.
    Takahashi K; Yonezawa K; Nishimoto I
    J Biol Chem; 1995 Aug; 270(32):19041-5. PubMed ID: 7642566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tyrosine mutations on the kinase activity and transforming potential of an oncogenic human insulin-like growth factor I receptor.
    Jiang Y; Chan JL; Zong CS; Wang LH
    J Biol Chem; 1996 Jan; 271(1):160-7. PubMed ID: 8550552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
    Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor.
    Burgaud JL; Baserga R
    Exp Cell Res; 1996 Mar; 223(2):412-9. PubMed ID: 8601418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
    Miura M; Li S; Baserga R
    Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells.
    Morrione A; Romano G; Navarro M; Reiss K; Valentinis B; Dews M; Eves E; Rosner MR; Baserga R
    Cancer Res; 2000 Apr; 60(8):2263-72. PubMed ID: 10786694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.